Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

InflaRx NV Stock

Price
Target price
€1.31

€1.31

0.390%
0.005
0.390%
€8.20
 
20:41 / Tradegate WKN: A2H7A5 / Symbol: IFRX / Name: InflaRx / Stock / Small Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of InflaRx NV in the next few years
Wizard

InflaRx NV Stock

InflaRx NV gained 0.390% compared to yesterday.
Our community is currently high on InflaRx NV with 5 Buy predictions and 1 Sell predictions.
With a target price of 8 € there is potential for a 513.03% increase which would mean more than doubling the current price of 1.31 € for InflaRx NV.
Our community identified positive and negative aspects for InflaRx NV stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the InflaRx NV stock. On the other hand our users think that "Innovation" could be a problem in the future.
What does InflaRx do?

Pros and Cons of InflaRx NV in the next few years

Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-15

InflaRx (NASDAQ: IFRX) is a company operating in the pharmaceutical industry, focusing on the development of therapies for different inflammatory diseases. A general observation of the financial statements reveals that the company experiences negative net income and operating income. However, the company has a healthy working capital and a solid stockholder equity. It is crucial to dive deeper into the financials to uncover more insights about the company's financial health and stability.

In conclusion, InflaRx's financials reveal some positive aspects, such as their healthy working capital and stable stockholder equity. However, the company's negative net income, negative operating income, and lack of steady revenue streams raise concerns about its long-term profitability and growth potential. Investors must weigh the pros and cons carefully before considering an investment in InflaRx (IFRX).

Show more

Comments

Prediction Buy
Perf. (%) -9.63%
Target price 7.385
Change
Ends at 22.03.25

InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
Show more

HC Wainwright 
0
Report Share
22.03.24
Prediction Buy
Perf. (%) -13.08%
Target price 7.381
Change
Ends at 25.01.25

InflaRx (NASDAQ: IFRX) had its price target lowered by analysts at HC Wainwright from $9.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for IFRX provided by MarketBeat
Show more

HC Wainwright 
0
Report Share
25.01.24
Prediction Buy
Perf. (%) -65.56%
Target price 8.393
Change
Ends at 12.09.24

InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
Show more

HC Wainwright 
0
Report Share
12.09.23
Show more
Not a member yet? Sign up for free!